Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited financial statements

Simcere Pharmaceutical Group Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueCNY 7.73BEODHD
Net incomeCNY 1.34BEODHD
Cash and equivalentsCNY 3.55BEODHD
Total debtCNY 1.2BEODHD

Simcere Pharmaceutical Group Limited financials on 6ix · Simcere Pharmaceutical Group Limited on 6ix